Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Loperamide
Drug ID BADD_D02428
Description One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
Indications and Usage For the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease or gastroenteritis. Also used for reducing the volume of discharge from ileostomies.
Marketing Status approved
ATC Code A07DA03
DrugBank ID DB00836
KEGG ID D08144
MeSH ID D008139
PubChem ID 3955
TTD Drug ID D0CS2F
NDC Product Code Not Available
UNII 6X9OC3H4II
Synonyms Loperamide | R-18553 | R 18553 | R18553 | Imodium | Loperamide Hydrochloride | Hydrochloride, Loperamide | Loperamide Monohydrochloride | Monohydrochloride, Loperamide
Chemical Information
Molecular Formula C29H33ClN2O2
CAS Registry Number 53179-11-6
SMILES CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Intestinal perforation07.04.06.002--Not Available
Irritability19.04.02.013; 08.01.03.0110.000507%
Joint stiffness15.01.02.003--Not Available
Joint swelling15.01.02.004--Not Available
Lethargy08.01.01.008; 19.04.04.004; 17.02.04.0030.001183%
Long QT syndrome02.03.01.0170.001014%Not Available
Loss of consciousness17.02.04.0040.000845%Not Available
Malaise08.01.01.003--
Muscle spasms15.05.03.004--
Muscular weakness17.05.03.005; 15.05.06.0010.000338%
Mydriasis06.05.03.004; 17.02.11.0030.000338%Not Available
Myocardial infarction24.04.04.009; 02.02.02.007--
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Nephrolithiasis20.04.01.002--
Neurotoxicity17.02.10.002; 12.03.01.0110.000676%Not Available
Pain08.01.08.004--
Pain in extremity15.03.04.010--
Painful respiration22.12.02.011--Not Available
Palpitations02.11.04.0120.000338%
Pancreatitis07.18.01.0010.000676%
Pancreatitis acute07.18.01.0020.000845%Not Available
Piloerection23.02.06.0050.000676%Not Available
Pleural effusion22.05.02.0020.000338%
Pre-eclampsia20.01.08.002; 18.02.03.002; 24.08.07.002--Not Available
Proctalgia07.03.02.001--
Productive cough22.02.03.005--
Pulmonary embolism22.06.02.001; 24.01.06.0010.000338%Not Available
Pyrexia08.05.02.0030.000676%
Rash pruritic23.03.13.030--Not Available
The 4th Page    First    Pre   4 5 6 7    Next   Last    Total 7 Pages